Peds RAP

Follow Peds RAP
Share on
Copy link to clipboard

Your work is hard; staying current shouldn’t be. Keep your practice ahead of the curve with entertaining, engaging and concise pediatric topics from world-class educators. This iTunes segment is just one monthly free segment of the full Peds RAP show. Get 3 hours of fresh podcast episodes per month…

Hippo Education LLC.,

  • Oct 16, 2020 LATEST EPISODE
  • every other week NEW EPISODES
  • 20m AVG DURATION
  • 61 EPISODES


Search for episodes from Peds RAP with a specific topic:

Latest episodes from Peds RAP

Failure to Thrive, Part 1

Play Episode Listen Later Oct 16, 2020 19:32


This free iTunes segment is just one tiny snippet of the fully-loaded 3-hour monthly Peds RAP show. Earn CME on your commute while getting the latest practice-changing peds information: journal article breakdowns, evidence-based topic reviews, critical guideline updates, conversations with experts, and so much more. Sign up for the full show at hippoed.com/PEDSRAPPOD. Michelle Thompson, MD, and Solomon Behar, MD discuss the diagnosis of and evaluation of a child with failure to thrive. Pearls: Failure to thrive is a weight for age that is less than the third percentile, a weight for height that is below the fifth percentile, or a weight that decreases two or more major percentile lines. There are generally three reasons kids fail to thrive; they do not take enough calories in, they take enough calories in but they do not properly absorb the calories, or their metabolic needs outweigh the amount of calories that they are taking in. The majority of the workup is in the history and physical exam.   What is failure to thrive (FTT)? Failure to thrive is the inavailability or unavailability of usable calories. Usually, it is in a child who is less than 2 years of age who meets certain criteria. The three most common criteria used clinically are: 1) a weight for age that is less than the third percentile, 2) a weight for height that is below the fifth percentile, and 3) a weight that decreases two or more major percentile lines. When babies are first born, they can be large and then at the two or four month visit they are crossing a number of growth percentage lines. How does this type of weight loss play into it? There is wiggle room for adjustment for large babies, preemie babies and babies with intrauterine growth restriction or IUGR.  When we talk about an initially large baby in the first months of life 0-3,  weight is generally more representative of the placental health and pregnancy factors. For a premature baby who is really tiny and starts out in the third percentile, how do you make the diagnosis of FTT?  We continue to plot preemie infants on a preemie growth chart until about two years of age.  You have to look at the velocity of the child’s weight and then take into consideration the height as well.  A child who is running below the third percentile consistently, but is tracking along a line below the third percentile, i.e. normal growth velocity, and the weight for height is demonstrating that he is on the normal curve, then genetically the baby may be programmed to be that way. That is not necessarily going to be defined as FTT. What about a child with a syndrome like Down syndrome who has their own growth curve? Can you do the same thing for them? Plotting along the available growth curves for those special populations when we have growth curves available is very important. To have a diagnosis of failure to thrive, you really do need to see the weight falling off the curve and dropping through percentiles. These days most children who have failure to thrive tend to have some combination of an underlying physical or developmental issue combined with environmental or social factors. Why do kids fail to thrive? There are generally three reasons kids fail to thrive. 1) The children are not getting enough calories 2)The children are getting enough calories, but they are not able to absorb the calories 3) The children have excess caloric expenditure because their metabolic needs outweigh the amount of calories that they are taking in.  This increased metabolic demand can be seen in  chronic hypoxemia, chronic lung disease, and congenital heart disease Let’s say you have a patient who comes to your clinic and he has dropped a few percentiles on his growth chart. Where do we start? Try to identify any patterns to the way the child is growing or not growing.  Look at the timing of the concern in the growth. For instance, if a child starts falling off the growth curve at an age when certain foods were introduced, then we might think about some sort of food allergy or intolerance, like celiac disease or a fructose intolerance. In what situation does the weight start falling off, but the height and head circumference are preserved? That means the child has inadequate nutrition. You can actually reach a point with malnutrition where the height and head circumference suffer as well, but typically you will see the weight drop off first, followed by the length or height and then ultimately if the child is not evaluated and is not treated, then the head circumference can fall as well. What if the weight and height and head circumference are all falling off together? What is that indicative of? If everything is falling off then typically I am thinking something like a central nervous system (CNS) abnormality or some sort of in utero insult. I go back to the birth parameters. Perhaps this child was IUGR.  Maybe there was a in utero congenital infection. What is the work up for FTT? I want to emphasize that the majority of the workup is in the history and physical exam. There will be some screening labs as well, but these are guided by the history and exam. Start off very general with dietary questions. “Tell about meal times in your home”. You really want to ask about what the child is eating and how much the child is eating.  Sometimes that means having the family actually do a meal by meal food recall or giving them a chart and having them fill that out at home and bring it back to the next visit. I want to know how the meal times are organized and if the meal times are scheduled.  Is the child seated at the table with other family members for meals? Are there distractions like TV? Is the child allowed to graze in between meals and play and eat at the same time? What do they drink in between meals? This is where a lot of the over consumption of juice and milk comes in.  Are there certain textures or types of foods that the child avoids? For example, some children with autism may avoid certain textures.  Or you may have a child who has an inborn error of metabolism that will basically avoid all proteins because every time he eats too much protein, he will start to throw up and feel sick. What other aspects of the medical history are  really important to ask about? You definitely you want to go back and get a good prenatal history and a perinatal history. Are there any concerns for in utero substance exposure, drugs or alcohol? Was there any prenatal stress? Was there any perinatal hypoxia or possibility for that? Is there a history of prematurity? What was the baby’s size at birth? Going through your systems review, you want to make sure that you are asking about any signs or symptoms that may be related to feeding intolerance. Is there a history of unexplained weight loss in the past? Is the child displaying any vomiting? Is there any evidence of choking with their feeds or difficulty swallowing? Do they have any respiratory symptoms that are chronic or recurrent? Is the child complaining constantly of abdominal pain? Do they have constipation or diarrhea? Urinary symptoms are important to ask about as well. You may find a kid producing too little or too much urine, which could be indicative of chronic renal disease or diabetes respectively. Unusual urine odors could be suggestive of an inborn error of metabolism. A history of recurrent infections is another important detail to inquire about. Too many episodes of otitis media or pneumonias that aren’t clearing could be suggestive of an immune deficiency. A history of rashes could be significant. A persistent rash could go along with any type of atopic history or allergic type history. Some of the immune problems are also associated with rashes. Moving onto the physical exam what are you looking for that is going to tip you off and give you that diagnosis of FTT? Start with  growth parameters and get a head circumference, even if you feel the child is older than the age where you normally would check a head circumference. Take a good look at dentition and examine the teeth  for any evidence of cavities. Actually watch the child eat something. If you cannot, then setting them up to be observed by a feeding specialist or occupational therapist is helpful. Examine the neck to see if there is a goiter or any abnormalities of the thyroid gland that we can feel. We want to evaluate for lymphadenopathy that maybe an indication of a chronic condition, oncologic condition or infection. Thoroughly examine  the heart, looking for any signs of congenital heart problems, listening for murmurs and extra heart sounds, and examining the pulses. Listen to the lungs. A child who is constantly wheezing or has adventitious lung sounds may have something  like cystic fibrosis or some other chronic respiratory issue. A thorough abdominal exam is important to check for masses and organomegaly. Checking for stool retention could indicate constipation or poor motility. Look around the anal area, looking for skin tags, fissures, or other signs of constipation may suggest some underlying gastrointestinal pathology. The skin exam is important as well.  Look for rashes or hypo- or hyperpigmented lesions that may be a sign of a genetic disease. On the neurological exam, look for any subtle signs of cerebral palsy or any kind of coordination issue involving mouth movements, chewing, or swallowing. If the history and the exam do not reveal the cause of FTT, what sort of preliminary lab tests do you do? At that point Thompson does a few preliminary labs with the understanding that sometimes this is going to be very low yield. Some of this testing may clue me into the sequelae of the nutritional issues that the child is having and every once in awhile may lead to the diagnosis. Start with a complete blood count (CBC). This can be  helpful especially in  looking at the hemoglobin and the indices for any indication of a nutritional anemia. We look for a microcytosis for iron deficiency or a  macrocytosis indicating a potential  vitamin B12 or a folate issue, especially if the child is very restrictive in their diet. Order a chemistry panel, specifically looking at the creatinine, and a urinalysis looking at the pH and the specific gravity. Make sure the child can properly concentrate her urine and can screen for renal tubular acidosis. Get an erythrocyte sedimentation rate (ESR) which is non-specific, but may help point to an underlying inflammatory condition. Consider  placement of  a PPD skin test  if there is concern for tuberculosis exposure or check a lead level if there are any other developmental concerns. Screen for thyroid disease with a thyroid stimulating hormone (TSH) level. How do you decide to admit a child for failure to thrive? If there is concern for the child’s immediate safety, admit the child to the hospital. For example, if we have uncovered that there is domestic violence or if there are signs of physical abuse, then  admit the child. If there is dehydration and we are at the stage where the child clinically does not seem like he will be able to keep up with at least the minimum of his fluid requirements, then admit to the hospital. If there has been a patient that is being followed and we have made interventions that have not resulted in appropriate weight gain, then consider  admission  to the hospital to expedite further work up. Another reason to admit a child to the hospital for failure to thrive would be a sudden acute weight loss or an excessive amount of weight loss. What are we doing once the child is in the hospital? As an inpatient, usually the expedited workup is engaging a multidisciplinary team to work together.  Sometimes that requires direct feeding observation by speech or occupational therapists. The therapists may suggest additional work up such as a modified barium swallow study. Dieticians can help us ramp up the calories for some of these kids who have really not had adequate nutrition for prolonged period of time. Is there any imaging that is routinely ordered? No, not really. This is going to be a case by case basis and guided by history and physical. Is there a definite connection between failure to thrive and parental mental health? Yes, this has  been described.  The mental health of whoever is responsible for spending time with the child during the day and feeding him will play a role. The caretaker’s own experience with feeding and nutrition even in their childhood can come into play.  Addressing issues related to the stressors and the mental health of the caretakers and providing resources for that are really important. One of the examples that Thompson uses is the child who grazes at the breast all day long. That is a source of comfort for the infant and also the mother who maybe tackling her own stressors. Putting the baby to the breast is a way for her to feel more comforted. The baby is basically just grazing all day and fails to thrive because she is not getting any other nutrition. What are the common things pediatricians should be doing in their offices before referring their patients either to the ER or to the hospital to get admitted for a FTT workup? Frequent follow up visits,, a really thorough history and a good physical exam. Your main goal in that very first visit is to determine if the child is in danger right now. If he is not, then you can do a history and a full physical and bring the child back. It is really over the course of more than one visit that you are going to get to the core of what the issues are and the interplay between those issues.  

Bilious Emesis in Neonates

Play Episode Listen Later Oct 16, 2020 23:56


This free iTunes segment is just one tiny snippet of the fully-loaded 3-hour monthly Peds RAP show. Earn CME on your commute while getting the latest practice-changing peds information: journal article breakdowns, evidence-based topic reviews, critical guideline updates, conversations with experts, and so much more. Sign up for the full show at hippoed.com/PEDSRAPPOD. Sol Behar, MD, and Jason Woods, MD discuss the evaluation and management of bilious emesis in a neonate.  Bilious emesis in an infant should be treated as an emergency because this is often a symptom of obstruction due to intestinal atresia or midgut volvulus. Causes of intestinal obstruction that present during the neonatal period include: Malrotation with or without volvulus Intestinal atresia Hirschsprung disease Intussusception (rare in the neonatal period) Necrotizing enterocolitis  Malrotation with volvulus. In this condition, the cecum is abnormally positioned in the right upper quadrant and this abnormal positioning predisposes the intestine to twist on its mesentery resulting in volvulus. This causes acute small bowel obstruction and ischemia.  An upper GI, the gold standard for diagnosing or evaluating malrotation, classically shows a duodenum with a "corkscrew" appearance. Intestinal atresia. This is a term used to describe a complete blockage or obstruction anywhere in the intestine. Approximately 30% of infants with duodenal atresia have a chromosomal anomaly, most typically Down syndrome. The "double bubble" sign is caused by dilation of the stomach and proximal duodenum and strongly suggests duodenal atresia Hirschsprung disease. This is a disorder of the motor innervation of the distal intestine that leads to a functional obstruction. In Hirschsprung, the nerves that allow the relaxation of the smooth muscle within the intestine wall are missing, so the area that is affected is constricted.   A contrast enema can support the diagnosis of Hirschsprung disease. It will often show the presence of a “transition zone” which represents the change from the normal caliber rectum to the dilated colon proximal to the aganglionic region.   For younger kids who have not had time to develop the “transition zone”, the rectosigmoid index, the ratio between the diameter of the rectum and the sigmoid colon, is typically >1 in normal children   Necrotizing enterocolitis. This is a condition characterized by bowel necrosis with associated severe inflammation, bacterial invasion, and dissection of gas into the bowel wall. Pneumatosis intestinalis, a hallmark of NEC, appears as bubbles of gas in the bowel wall. Meconium ileus is caused by the obstruction of the small intestines with inspissated meconium. Approximately 10% of patients with CF present with meconium ileus.

Cephalosporins - Part One

Play Episode Listen Later Oct 16, 2020 16:54


This free iTunes segment is just one tiny snippet of the fully-loaded 3-hour monthly Peds RAP show. Earn CME on your commute while getting the latest practice-changing peds information: journal article breakdowns, evidence-based topic reviews, critical guideline updates, conversations with experts, and so much more. Sign up for the full show at hippoed.com/PEDSRAPPOD. Pediatric ID specialist Michael Neely, MD, and Michael Cosimini, MD discuss how cephalosporins work and which bugs they do and do not kill. Pearls: In general, cephalosporins do not cover anaerobes, enterococcus, listeria and MRSA. Oral cephalosporins are generally not first line in pediatrics.  Some exceptions include the treatment of UTIs and some skin and soft tissue infections; group A strep and sinopulmonary infections in penicillin allergic patients are other common indications. 1st generation cephalosporins do have gram positive coverage, but do not work well against strep pneumo, MRSA, enterococcus. They do cover some enteric gram negative bacteria, the “PECK” organisms.   What are cephalosporin antibiotics and how do they compare to penicillins?  Chemically, both penicillins and cephalosporins are beta-lactam antibiotics, with the beta-lactam portion responsible for bacterial killing.  The chemical portions off the beta-lactam ring make the antibiotics different. Beta-lactam antibiotics work by binding to the penicillin-binding protein on the bacterial cell wall.  These proteins have structural functions that maintain the integrity of the bacterial cell wall and therefore, when these antibiotics bind, the penicillin-binding protein is disrupted, the cell wall falls apart and the bacterial dies.       How do you keep a straight spectrum of activity for antibiotics?  To help with this, think of bacteria into big categories: gram-positive, gram-negative and “other”. Gram-positive bacteria include: Staph aureus (MSSA, MRSA), Streptococcus (Group A Strep, Group B Strep, Strep pyogenes, Strep viridans), Enterococcus, Pneumococcus, Listeria Gram-negative bacteria are a much bigger group and can be divided into: Respiratory gram-negatives include Moraxella, Haemophilus, Meningococcus Enteric gram-negatives include the “PECK” bacteria: Proteus, E.coli, Klebsiella What bacteria do cephalosporins not cover?  In general, cephalosporins do not cover anaerobic bacteria, enterococcus, listeria and MRSA.  There are a few exceptions to this rule. Cefoxitin (a second generation cephalosporin), for example, does have anaerobic coverage.  It is commonly used in the treatment of PID as it covers enteric anaerobes and Neisseria gonorrhea. There is a 5th generation cephalosporin that does cover MRSA (discussed later). Are cephalosporins well absorbed?  Generally speaking, cephalosporins in oral formulations are not as well absorbed as penicillins and are more difficult to get where they need to go outside the urinary tract. Also, generally speaking, no beta-lactam really gets into the spinal fluid in very high concentrations; all of them do have better penetration when there is inflammation.  Practically, remember that the penetration into the CSF between ampicillin and ceftriaxone is negligible. What bacteria do first generation cephalosporins cover?  Although the classic teaching is that cephalosporins are good for gram-positive coverage (staph and strep), this is not a hard and fast rule.  As stated, enterococcus is not covered by any cephalosporin and MRSA is not covered by most cephalosporins.  First generation cephalosporins are also good for coverage of the “PECK” enteric gram negative bacteria, but not good for coverage of other gram negative bacteria.  These organisms tend to cause UTIs and therefore, first generation cephalosporins (for example, cephalexin) are frequently used for UTI treatment. Of course, resistance can occur.    Even though strep pneumo is a gram-positive organism, when it comes to first generation cephalosporins, it acts like a gram-negative organism and therefore, first generation cephalosporins do not work well against strep pneumo.   What about bacteria that develop resistance?  A patient with an E. Coli UTI, for example, may have a microbiology laboratory report stating that the E. Coli is resistant to a first generation cephalosporin but the patient is still getting better.  This may have to do with the type of infection the patient had; for example, a healthy patient with a simple cystitis may have been able to stay well hydrated and the normal immune system was able to clear the E. Coli. This question can also be answered in the context of breakpoints, that is when the bacteria become susceptible or resistant to the antibiotic depending on the site of infection.  Some labs will actually label a bacteria resistant or susceptible depending on whether the infection is in the urine, spinal fluid or blood. Therefore, if a lab that reports site-specific breakpoints suggests that an E. Coli is resistant to a first generation cephalosporin in the urine, the lab has already taken into account the higher concentration of drug in the urine.  Similarly, a pneumococcal isolate that may be resistant to ceftriaxone in the CNS may be susceptible to ceftriaxone as a pneumonia because there are much higher concentrations of ceftriaxone in the lungs than in the spinal fluid. When should a skin or soft tissue infection be treated with a first-generation cephalosporin?  When should MRSA be suspected? This can be a tricky question as an outpatient, but there are some clues to gauge whether or not the infection may be caused by MRSA.   One, it is helpful to know the community prevalence of MRSA.  In some communities, community acquired staph aureus infections are up to 80-90% MRSA.  In these communities, MRSA coverage should of course be given. If the prevalence is much lower, using a first generation cephalosporin, such as cephalexin may be reasonable.   Other clues can be more specific to the patient the their families.  Is the patient or family known to be colonized with MRSA? Have they had an MRSA infection in the past? If MRSA coverage is needed, either trimethoprim-sulfa or clindamycin generally is a good approach.  A randomized controlled trial published in the NEJM showed no difference in outcomes when treating a known MRSA infection. Miller LG et al.  Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.  N Engl J Med. 2015 Mar 19;372(12): 1093-103. https://www.ncbi.nlm.nih.gov/pubmed/25785967 In general, the quality of the infection does not help point to MRSA or not.  There is some suggestion that if there is a soft-tissue abscess this is more likely staph aureus and if there is just pure erythema, tenderness and warmth without abscess, this is more likely to be Group A strep.   Remember, no matter what antibiotic is started for cellulitis (or any infection, for that matter), follow up is essential.  If you are on the right antibiotics, cellulitis should be improving within 24 hours.

Herpes Simplex - Part One

Play Episode Listen Later Oct 16, 2020 27:28


This free iTunes segment is just one tiny snippet of the fully-loaded 3-hour monthly Peds RAP show. Earn CME on your commute while getting the latest practice-changing peds information: journal article breakdowns, evidence-based topic reviews, critical guideline updates, conversations with experts, and so much more. Sign up for the full show at hippoed.com/PEDSRAPPOD. Andi Marmor, MD, and Lisa Patel, MD review the cutaneous and systemic manifestations of HSV1, when testing is indicated, potential co-infections, and discuss management strategies depending on presentation. Transmission of HSV-1 occurs when someone with no prior infection comes in contact with herpetic lesions, mucosal secretions, or skin lesions that contain HSV-1. Transmission can occur when infected body secretions come into contact with a break in the skin.  In the acute phase of the infection, the herpes virus replicates at the site of contact. From there, the virus enters the sensory nerve and travels to the ganglion. Typically it establishes latency in the trigeminal nerve ganglion (or sacral ganglion depending on the initial site of infection) and it can then reactivate in any of the branches of that nerve throughout life. HSV PCR and viral culture are the two tests used to confirm the diagnosis of  HSV. A viral culture can distinguish between HSV-1 and HSV-2. HSV PCR is typically faster and more sensitive than a viral culture.  Serologic testing has a limited role in acute infection but can be helpful in establishing prior infection in someone who is, for example, undergoing an organ transplant where antiviral prophylaxis might be needed.  Primary HSV-1 oral infection usually presents as gingivostomatitis in children. High fevers and malaise are the typical prodromal symptoms which are then followed by the development of painful vesicular lesions. Lesions can affect the entire gingiva and also often involves the buccal mucosa, tongue, and the floor of the mouth. There may also be some sores on the outside of the mouth and around the lips. In coxsackievirus, the majority of the lesions are in the posterior oropharynx whereas with HSV gingivostomatitis, the majority are in the anterior mouth. The distribution of the lesions can help distinguish between the two viruses.  Children with gingivostomatitis may require hospitalization for pain control and/or dehydration.  For pain management, Andi advises using around the clock NSAIDs and does not recommend using Magic mouthwash. Magic mouthwash is typically a 1:1:1: ratio combination of viscous lidocaine, diphenhydramine, magnesium hydroxide (or aluminum hydroxide) mixed with a flavored syrup. Andi does not recommend because 1) viscous lidocaine is well absorbed through the oral mucosa and can quickly reach a toxic level in young kids and 2) there is not much evidence showing that improves pain control or that helps kids hydrate.  Honey was shown in a recent randomized control trial to both improve pain control and less than the time to healing.  Acyclovir, in addition to supportive care measures, is recommended in children with severe symptoms and who present within 72-96 hours of disease onset. A Cochrane review from 2008 showed that it decreased the time to healing and lessened the amount of pain medicine needed. The typical dosing is 15 mg/kg by mouth (maximum single dose 200 mg) five times per day. Herpetic whitlow is an infection of the soft tissue of the finger caused by HSV. It is usually localized to the nailfold. These lesions are initially clear-yellow vesicles that then coalesce into a larger blister. Herpetic whitlow is often confused with a bacterial infection like paronychia or a pulp abscess. Unlike a paronychia, the area filled with pus is not tense in the setting of herpetic whitlow. Treatment in most cases is doing nothing. The time that this takes to resolve is two to three weeks. Consider treatment with acyclovir if it is on multiple digits, if the child is systemically ill, or if there is concern for a more widespread infection. Herpes gladiatorum is a skin infection that classically occurs on the face, neck, and arms of wrestlers. Eczema herpeticum is a widespread HSV infection of the skin in a patient with pre-existing atopic dermatitis. Vesicles and characteristic "punched-out" lesions with hemorrhagic crust appear on areas of pre-existing skin disease.  Complications of eczema herpeticum include a superimposed bacterial infection, particularly with Staph. Because of the potential seriousness of this condition, treatment with systemic acyclovir is recommended oftentimes with an anti-staphylococcus medication in addition.  The continued use of topical corticosteroid for the treatment of the underlying eczema is somewhat controversial but a recent paper in Pediatric Dermatology showed that receipt of topical steroids did not prolong hospitalization.  The most common secondary reactivation is recurrent herpes labialis or cold sores of the lip - that is a recurrence of HSV that has been lying dormant in the trigeminal ganglion. Triggers for recurrence include immunodeficiency, stress, exposure to sunlight, and fevers.  The lesions are typically present along the vermilion border but they can also be present on the oral mucosa. Most patients have prodromal symptoms including pain, burning, or tingling,  Topical treatments, such as Penciclovir, have shown some benefits. However, given the need for frequent application, some people advocate for the use of oral acyclovir. Oral therapy has been shown to shorten the course of infection when taken during the prodromal period.  Chronic suppressive therapy is recommended if recurrences are happening four or more times a year and there is no predictable prodrome.  Herpes keratitis is a corneal infection that is caused by reactivation of herpes virus that has been latent in the trigeminal ganglion. It tends to present as a unilateral, uncomfortable tearing eye with redness and irritation.  On fluorescein exam, you will see dendritic lesions. Patients should be referred to Ophthalmology for a slit lamp exam and for monitoring the integrity of the cornea.  Herpes virus can cause peripheral facial nerve palsy. In a peripheral seventh nerve palsy, there is weakness affecting the mouth, eye and forehead. It is the involvement of the forehead musculature that distinguishes it from a central lesion. Patients with a peripheral facial nerve palsy will have weakness raising the eyebrow and wrinkling the forehead. Neonatal HSV is classified into three categories: localized skin, eye and mouth (SEM); CNS and disseminated disease.  SEM disease is associated with typical herpes ulcers on the face or on the mucous membranes seizures and encephalopathy. Manifestations of neonatal HSV CNS disease include seizures and encephalopathy Disseminated HSV has a sepsis-like presentation, involving multiple organs. These neonates are critically ill.  Women with a primary genital HSV infection acquired near the time of delivery have the highest risk for transmission.  HSV encephalitis is mainly caused by HSV-1, whereas meningitis is more often caused by HSV-2

LARCs Part 1

Play Episode Listen Later Sep 1, 2020 19:23


According to the 2017 Youth Risk Behavior Survey, nearly 40% of US teens reported ever having sex; however, only 54% reported using a condom at last intercourse, 37% reported using a hormonal method, and 14% reported not using anything to prevent pregnancy. On the flip side, we know that long-acting reversible contraceptives are recommended as first-line for adolescents for contraception. So why aren’t teens using them? Join Megen Vo, MD, and Lisa Patel, MD for this important conversation.  To view the references for this segment CLICK HERE

Health Disparities with Dr. Utibe Essien

Play Episode Listen Later Aug 27, 2020 23:58


In this Hippo Education bonus conversation, Drs. Jay-Sheree Allen and Neda Frayha sit down with noted health disparities researcher Dr. Utibe Essien, an Assistant Professor of Medicine at the University of Pittsburgh School of Medicine and Core Investigator for the Center for Health Equity Research and Promotion at the VA Pittsburgh Healthcare System. They explore reasons for disparities in the health care outcomes of our patients, disparities in the diversity of our medical profession, and the crucial bridge that connects these two. They close with three concrete steps we all can take to improve our clinical practice and reduce health disparities in our patient communities. CLICK HERE to view the references and join our thriving online community of clinicians.

Pediatric COVID-19: Lit Review

Play Episode Listen Later Aug 17, 2020 16:24


Pediatricians Roy Benaroch and Geoff Simon break down the latest literature on Pediatric COVID-19.

Cyanotic congenital heart disease Pt.01 ("The Cardiac Blues")

Play Episode Listen Later Aug 3, 2020 26:06


You’re called to the nursery to evaluate a baby with low oxygen saturations who is looking blue. How do you know if it’s cardiac or pulmonary and what can you do to distinguish the two? What steps do you need to take to stabilize this baby?  Luckily, Andi Marmor, MD sits down with UCSF pediatric cardiologist Jeffrey Gossett MD to discuss cyanotic congenital heart disease and answer these questions and so many more. Click Here to view references and show notes

Racism and Child Health

Play Episode Listen Later Jul 29, 2020 28:50


Race and health are inextricably linked to each other. Pediatricians Nathan Chomilo and Michael Cosimini break down the AAP Policy Statement on the health effects of racism on children. To view the references from this segment Click Here

Race and Medicine - An Introduction

Play Episode Listen Later Jul 14, 2020 20:44


In recent weeks, many of our medical organizations have released official statements declaring racism to be a public health crisis. In this introduction to Hippo Education’s new Race and Medicine audio series, Dr. Jay-Sheree Allen sits down with Primary Care RAP host Dr. Neda Frayha for a candid conversation exploring the definition and types of racism, the historical and present-day manifestations of racism in medicine, and potential strategies we all can incorporate into our daily practices to go beyond the hashtag and become true allies.  To view the references for this segment: Click Here    

Bilious Emesis in Neonates

Play Episode Listen Later Jul 5, 2020 24:57


Sol Behar, MD and Jason Woods, MD get together to discuss the evaluation and management of bilious emesis in a neonate.    Bilious emesis in an infant should be treated as an emergency because this is often a symptom of obstruction due to intestinal atresia or midgut volvulus. Causes of intestinal obstruction that present during the neonatal period include: Malrotation with or without volvulus Intestinal atresia Hirschsprung disease Intussusception (rare in the neonatal period) Necrotizing enterocolitis  To view all the rest of the incredible show notes and see all the  references Click Here 

Laceration Repair in the Time of COVID

Play Episode Listen Later Jun 16, 2020 15:10


Drs. Brian Lin and Mike Weinstock discuss alterations to our usual practice patterns of laceration repair in the setting of the COVID pandemic, which include increasing patient throughput through faster closure techniques, reducing total points of contact with the healthcare system by using techniques to obviate the need for a return visit, and habit changes during closure to minimize exposure risk during face-to-face contact.   To view the references and show notes from this podcast Click here

COVID Antibodies and Immunity

Play Episode Listen Later Jun 16, 2020 17:59


Dr. Mizuho Morrison & Dr.Jenny Beck Esmay both having had covid themselves, briefly discuss the clinical course and what presence of IgM vs. IgG signifies. They discuss what we currently know about antibody testing (national availability, reliability, sensitivity) as well as convalescent plasma transfusion (CPT) and criteria for donation vs. recipient.   To view the references and show notes from this podcast Click here  

*UPDATED* - The Saga Continues with Remdesivir and Hydroxychloroquine

Play Episode Listen Later Jun 15, 2020 9:20


*Editor's note: As of June 4, 2020, The Lancet article by Mehra MR et al has been retracted. (https://www.thelancet.com/lancet/article/s0140673620313246) In this Hippo Education short, Dr.Salim Rezaie from REBEL EM and Lit Matters critically appraises two papers published on Friday May 22nd, 2020.  He discusses what the evidence shows for both remdesivir & hydroxychloroquine/chloroquine as effective treatment or prophylaxis for COVID-19.   To view the references and show notes from this podcast Click here

COVID CARDIOLOGY

Play Episode Listen Later Jun 15, 2020 27:59


COVID-19 causes STEMI’s, arrhythmias and myocarditis?!? Emergency medicine and cardiology guru Amal Mattu, MD chats with Mizuho Morrison, DO on the cardiovascular effects of COVID-19. They discuss: the known pathophysiology of how viral infections affect the heart; Review the new consensus statement from the Society of Cardiovascular Angiography and interventions (SCAI), American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP) on how to manage STEMIs; and lastly discuss how cardiac arrest management differs in this COVID era.    To view the references and show notes from this podcast Click here

Indirect Impact of COVID-19 on Children

Play Episode Listen Later Jun 14, 2020 17:06


Children seem to be less affected than adults by the direct effects of COVID-19 infection, but the pandemic has brought forth other health risks to the pediatric population. Sol Behar interviews Oakland, CA based primary care pediatricians Celine Sparrow and Katie D’Harlingue about the indirect impact of COVID-19 on children. Topics covered include home school and academic achievement, mental health issues, and nutrition/food insecurity.    To view the references and show notes from this podcast Click here

MOCA Time: Social Media Risks in Children

Play Episode Listen Later Jun 3, 2020 27:03


General pediatrician Cori Cross, MD and Sol Behar, MD review the good, the bad, and the annoying (for parents) aspects of social media use in children. To view the show notes and references for this episode CLICK HERE

COVID-19: IDSA Treatment Guidelines, Remdesivir, and a Look Back

Play Episode Listen Later May 18, 2020 23:52


In this Hippo Education update, Primary Care RAP host Dr. Neda Frayha interviews regular guest and Infectious Diseases expert Dr. Devang Patel for a discussion of where the IDSA stands on all the potential treatments for COVID-19, a review of the remdesivir paper that is all the rage lately, and a look back on whether or not their very first conversations on the novel coronavirus have stood the test of time.    To view the references and show notes from this podcast Click here

COVID Findings in Kids

Play Episode Listen Later May 18, 2020 25:18


Sol Behar, MD interviews New York City pediatric emergency physician Dr. Ee Tay, highlighting the features of pediatric COVID disease, including an emerging illness that is being compared to Kawasaki Shock Syndrome called “pediatric inflammatory multisystem disease” (PIMS). To view the references and show notes from this podcast Click here

COVID-19: The Long Game

Play Episode Listen Later May 8, 2020 27:26


Dr. Matthieu DeClerck talks to Dr. Manie Beheshti on how the healthcare system should approach the “re-opening” of society as we plan the lifting of social restrictions. What safety implementations need to be in place in order to protect our most vulnerable patients. What changes can we anticipate in the healthcare system moving forward?  To view the references and show notes from this podcast Click here  

MOCA TIme: Mechanical Ventilation Basics

Play Episode Listen Later May 4, 2020 26:12


UCSF pediatric intensivist Mindy Ju, MD breaks down the basic principles of mechanical ventilation in children with Solomon Behar, MD For references and to read the show notes Click Here Subscribe today for 3.5 hours of incredible content each month. 

Clinician Mental Health in the COVID-19 Pandemic

Play Episode Listen Later May 1, 2020 23:16


Psychiatrist Dr. Melissa Shepard sits down with Primary Care RAP host Dr. Neda Frayha for some real talk on the mental health challenges facing health care workers in the COVID-19 pandemic, and some concrete, tangible tools to help us get through this period. Spoiler alert: it’s more than yoga.    To view the references and show notes from this podcast Click here

COVID - Pandemic Malpractice Issues

Play Episode Listen Later Apr 26, 2020 22:45


Dr. Matthew DeLaney and Dr. Michael Weinstock sit down to discuss the threat of lawsuits in the midst of the COVID pandemic. The last thing anyone wants to think about is the risk of a lawsuit. Unfortunately, despite the extra challenges posed by our current pandemic, the threat of medicolegal consequences remains. In this segment, we evaluate the unique medicolegal risks that can occur during disaster situations and look at potential sources of medicolegal protection. To view the references and show notes from this podcast Click here  

COVID CXR Study and Findings in Ambulatory Patients

Play Episode Listen Later Apr 23, 2020 16:49


Drs. Mike Weinstock and Josh Russell, from Urgent Care RAP, just published a landmark COVID study: CXRs obtained from confirmed and symptomatic COVID-19 patients presenting to the UC were normal in 58.3% of cases, and normal or only mildly abnormal in 89% of patients. Matthew DeLaney, MD joins in on the conversation in this important podcast. To view the references and show notes from this podcast Click here

COVID-19 Lessons From NYC

Play Episode Listen Later Apr 15, 2020 22:44


Patients with COVID-19 present in a variety of ways and clinicians need to have a low index of suspicion for diagnosis. Management involves emergency referrals for patients with low oxygen saturation. Every patient should be treated as if they could have COVID-19. Mike Weinstock, MD, and Matthieu DeClerck, MD are joined by Frank Illuzzi, MD in this very important segment.  To view the references and show notes from this podcast Click Here

COVID 19: Hot Topics and Lit Review

Play Episode Listen Later Apr 8, 2020 23:02


There are so many active threads, subthreads, and sub-sub-threads of conversation in the medical community surrounding the COVID-19 pandemic. In this Hippo Education Short, Tom Robertson, MD and Steve Biederman, MD of Primary Care RAP’s Paper Chase take 4 hot topics in COVID-19 and examine the literature behind them. They look into the epidemiology of the outbreak in the U.S. and lessons learned, the sensitivity and specificity of SARS-CoV-2 testing, the rates of co-infection with other respiratory viruses, and convalescent plasma as a potential therapy. To view the references and show notes from this podcast Click Here

COVID-19 Pharmacology

Play Episode Listen Later Apr 6, 2020 17:44


Mizuho Morrison, DO sits down with emergency medicine pharmacist/toxicologist Bryan Hayes, PharmD to answer some pertinent questions and myth-bust clarifications about pharmaceutical options in COIVD-19 treatment. To view the references and show notes from this podcast Click Here

Constipation - Part One

Play Episode Listen Later Apr 1, 2020 23:05


Andi Marmor, MD and Lisa Patel, MD discuss why functional constipation occurs, the evidence behind prevention and treatment, appropriate treatment regimens for the outpatient setting, and when patients should be referred for inpatient clean out for constipation. To hear Part Two of this conversation and to view the show notes and references click here

Covid-19: Pregnancy and Newborns

Play Episode Listen Later Apr 1, 2020 15:19


Sol Behar, MD interviews Children’s Hospital of Philadelphia NICU doc Joanna Parga-Belinkie, MD to discuss Covid-19 and some of the peripartum issues that come up during the novel coronavirus pandemic for both pregnant moms and their newborns. For the show notes and additional references please click here  

Telemedicine in the Time of COVID-19

Play Episode Listen Later Mar 30, 2020 21:27


Has your clinical practice shifted to telemedicine yet? In the era of COVID-19, clinicians everywhere are being thrown into telemedicine, often without any experience or background knowledge. To help us all get up to speed with this patient care technology, Hippo Education’s Dr. Neda Frayha sits down with Dr. Edward Kaftarian, the Vice Chair of Mental Health at the American Telemedicine Association and CEO of Orbit Health Telepsychiatry. Together they explore the benefits and potential pitfalls of telemedicine, the equipment required, billing and coding considerations, appropriate etiquette, and much more. For more information and to view all the detailed notes and get all the references for this segment please click here

What if I get called in to help with COVID patients? - Ep 00:Introduction

Play Episode Listen Later Mar 24, 2020 2:12


We know that there's a constant flood of information. So, we produced this podcast mini-series to help rapidly onboard healthcare professionals who don’t see COVID-19 patients regularly. We’re going to keep this simple and short, something you can listen to on your drive into work. We'll point out key clinical pearls and pitfalls that we've learned on the frontlines to help keep you and your patients safe. You can do this. Featuring Aaron Bright, MD and Salim Rezaie, MD

What if I get called in - Ep 01: Personal Protective Equipment (PPE)

Play Episode Listen Later Mar 24, 2020 7:08


Most healthcare professionals know what personal protective equipment (PPE) is, but the reality is that many of us don’t use this everyday and are wondering if we’re doing it correctly. Let’s highlight where people make mistakes and expose themselves to risk. Featuring Aaron Bright, MD and Salim Rezaie, MD

What if I get called in - Ep 02: Management basics for suspected COVID-19

Play Episode Listen Later Mar 24, 2020 8:56


For healthcare professionals who may get called in to help with COVID-19 patients, you will most likely be asked to help triage and manage ambulatory suspected COVID-19 patients. Here’s what you need to know. Featuring Aaron Bright, MD and Salim Rezaie, MD

What if I get called in - Ep 03: How respiratory interventions change for suspected COVID-19

Play Episode Listen Later Mar 24, 2020 7:31


Most healthcare professionals are familiar with oxygen supplementation and nebulizers, maybe even CPAP/BiPAP. Most of us should have some Basic Life Support (BLS) training to use a bag-valve-mask (BVM) in case of emergency. But there are some of this changes with COVID-19. Featuring Aaron Bright, MD and Salim Rezaie, MD

What if I get called in - Ep 04: Diagnostic and radiology pitfalls in COVID-19

Play Episode Listen Later Mar 24, 2020 4:57


For healthcare professionals who do not often receive immediate laboratory results and diagnostic imaging reports, we’ll highlight unique diagnostic patterns and pitfalls with COVID-19 patients. Featuring Aaron Bright, MD and Salim Rezaie, MD

What if I get called in - Ep 05: Provider self-care tips during the COVID pandemic

Play Episode Listen Later Mar 24, 2020 4:21


As healthcare professionals, we all recognize the increased risks we face as we care for our patients during the COVID-19 pandemic, but we must also care for ourselves, especially when we come home to our families. It’s normal to be concerned and one of the first things we can do is to start having conversations and plan ahead. Featuring Aaron Bright, MD and Salim Rezaie, MD

Hippo Education - Update- Impact of COVID-19 on Healthcare Workers

Play Episode Listen Later Mar 17, 2020 19:38


Our panel of podcast hosts from a variety of practice settings discuss the logistical and psychological impact of the COVID-19 pandemic on healthcare workers and discuss strategies to mitigate the stress associated with the pandemic. Featuring: Solomon Behar, MD, Neda Frayha, MD, Mike Weinstock, MD, and Matthieu DeClerck, MD References: Click Here

Hippo Education - PEDS:RAP Short - COVID-19 Update

Play Episode Listen Later Mar 9, 2020 23:05


In this Hippo Education Short, Infectious Diseases specialist Dr. Devang Patel and our own Dr. Neda Frayha discuss the latest, clinician-focused updates on the COVID-19 coronavirus outbreak.  Subscribe to PEDS:RAP today to support this show and the important work being done to provide you with the most up-to-date medical knowledge from the world experts in the field.  https://www.hippoed.com/ For References go to:  https://www.hippoed.com/peds/rap/episode/bonusshortcovid/covid19update

Measles: In the Trenches

Play Episode Listen Later Mar 1, 2020 33:27


Solomon Behar, MD interviews Portland, Oregon based doctors Holly Tse, MD (urgent care) and Paul Lewis, MD (infectious disease and public health) to chat about the real world experience of responding to the measles outbreak in their community.    There is so much more to PedsRAP each month. For more incredible education and 42 hours of CME CLICK HERE!    

Herpes Simplex - Part One

Play Episode Listen Later Feb 1, 2020 28:29


Andi Marmor, MD and Lisa Patel, MD review the cutaneous and systemic manifestations of HSV1, when testing is indicated, potential co-infections, and discuss management strategies depending on presentation. For more incredible segments like this, subscribe to PC:RAP today. You'll never miss a moment of the program and earn 42 hours of CME per year.  Transmission of HSV-1 occurs when someone with no prior infection comes in contact with herpetic lesions, mucosal secretions, or skin lesions that contain HSV-1. Transmission can occur when infected body secretions come into contact with a break in the skin.  In the acute phase of the infection, the herpes virus replicates at the site of contact. From there, the virus enters the sensory nerve and travels to the ganglion. Typically it establishes latency in the trigeminal nerve ganglion (or sacral ganglion depending on the initial site of infection) and it can then reactivate in any of the branches of that nerve throughout life. HSV PCR and viral culture are the two tests used to confirm the diagnosis of  HSV. A viral culture can distinguish between HSV-1 and HSV-2. HSV PCR is typically faster and more sensitive than a viral culture.  Serologic testing has a limited role in acute infection but can be helpful in establishing prior infection in someone who is, for example, undergoing an organ transplant where antiviral prophylaxis might be needed.  Primary HSV-1 oral infection usually presents as gingivostomatitis in children.High fevers and malaise are the typical prodromal symptoms which are then followed by the development of painful vesicular lesions. Lesions can affect the entire gingiva and also often involves the buccal mucosa, tongue, and the floor of the mouth. There may also be some sores on the outside of the mouth and around the lips. In coxsackievirus, the majority of the lesions are in the posterior oropharynx whereas with HSV gingivostomatitis, the majority are in the anterior mouth. The distribution of the lesions can help distinguish between the two viruses.  Children with gingivostomatitis may require hospitalization for pain control and/or dehydration.  For pain management, Andi advises using around the clock NSAIDs and does not recommend using Magic mouthwash. Magic mouthwash is typically a 1:1:1: ratio combination of viscous lidocaine, diphenhydramine, magnesium hydroxide (or aluminum hydroxide) mixed with a flavored syrup. Andi does not recommend because 1) viscous lidocaine is well absorbed through the oral mucosa and can quickly reach a toxic level in young kids and 2) there is not much evidence showing that improves pain control or that helps kids hydrate.  Honey was shown in a recent randomized control trial to both improve pain control and less than the time to healing.  Acyclovir, in addition to supportive care measures, is recommended in children with severe symptoms and who present within 72-96 hours of disease onset. A Cochrane review from 2008 showed that it decreased the time to healing and lessened the amount of pain medicine needed. The typical dosing is 15 mg/kg by mouth (maximum single dose 200 mg) five times per day. Herpetic whitlow (see image below, photo credit: Solomon Behar)  is an infection of the soft tissue of the finger caused by HSV. It is usually localized to the nailfold. These lesions are initially clear-yellow vesicles that then coalesce into a larger blister. Herpetic whitlow  is often confused with a bacterial infection like paronychia or a pulp abscess.  Unlike a paronychia, the area filled with pus is not tense in the setting of herpetic whitlow. Treatment in most cases is doing nothing. The time that this takes to resolve is two to three weeks. Consider treatment with acyclovir if it is on multiple digits, if the child is systemically ill, or if there is concern for a more widespread infection.

Bonus Short - Novel Coronavirus

Play Episode Listen Later Jan 30, 2020 18:05


In this Hippo Education Short, Infectious Diseases specialist Dr. Devang Patel sits down with our own Dr. Neda Frayha to discuss what we know so far about the new 2019-n-CoV coronavirus outbreak and what front-line clinicians can do if we suspect a patient of ours might have this viral illness.  References: Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 24 Jan 2020. DOI: 10.1056/NEJMoa2001017.  Munster VJ, Koopmans M, van Doremalen M, et al. A novel coronavirus emerging in China - key questions for impact assessment. N Engl J Med, 24 Jan 2020. DOI: 10.1056/NEJMp2000929 Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 24 Jan 2020. https://doi.org/10.1016/ S0140-6736(20)30183-5    Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 24 Jan 2020. https://doi.org/10.1016/S0140-6736(20)30154-9 Phan LT, Nguyen TV, Luong QC, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med, 28 Jan 2020. DOI: 10.1056/NEJMc2001272 Wuhan Coronavirus - 2019-n-CoV. Infectious Diseases Society of America. https://www.idsociety.org/public-health/wuhan-coronavirus/. Accessed 29 Jan 2020 2019 Novel Coronavirus (2019-n-CoV), Wuhan, China. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/summary.html. Accessed 29 Jan 2020. Update and Interim Guidance on Outbreak of 2019 Novel Coronavirus (2019-n-CoV) in Wuhan, China. Centers for Disease Control and Prevention. https://emergency.cdc.gov/han/han00426.asp. Accessed 29 Jan 2020.   Resource: Centers for Disease Control and Prevention 2019-n-CoV PUI Case Investigation Form: https://www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdfpdf icon

Group A Streptococcal (GAS) Pharyngitis | Part 1

Play Episode Listen Later Jan 1, 2020 20:58


Andi Marmor, MD and Sol Behar, MD review clinical features, complications, and latest treatment options of strep pharyngitis. GAS as a cause of pharyngitis is most commonly observed in children 5–15 years of age. Diagnostic studies for GAS pharyngitis are not recommended for children under 3  because acute rheumatic fever is rare in children

Opioids - Part One

Play Episode Listen Later Dec 2, 2019 23:40


Rita Agarwal, MD and Lisa Patel, MD discuss safe prescribing practices in the age of the opioid epidemic.  Rita outlines when opioids are appropriate for pain management versus when to consider other medications or modalities.  She discusses the PILLS pneumonic to counsel families on storage, safety, and disposal of these medications. And she discusses how to manage patients with difficult to treat pain syndromes. Click here and subscribe to hear Part 2 and get 3.5 hours of CME each month CLICK HERE! 

Peripartum practices

Play Episode Listen Later Nov 1, 2019 27:50


Sol Behar, MD and CHOP NICU doc Joanna Parga-Belinkie, MD review the evidence behind some of the peripartum practices that happen in the delivery room and in the immediate aftermath. There is so much more to PedsRAP each month. For more incredible education and 42 hours of CME CLICK HERE!  

High Flow Nasal Cannula in Bronchiolitis | Part 1

Play Episode Listen Later Oct 1, 2019 14:20


High flow nasal cannula is being used with increasing frequency on pediatric ward floors for children with bronchiolitis.  Lisa Patel, MD and Andi Marmor, MD discuss the evidence on its use to reduce escalation of care and decrease length of stay. They also discuss how to start, titrate and wean settings on HFNC.   There is so much more to PedsRAP each month. To listen to Part 2 of this incredible segment and even more incredible education along with 42 hours of CME CLICK HERE!  

VAPI: Vaping Associated Pulmonary Injury

Play Episode Listen Later Sep 18, 2019 17:42


Given the recent spike of VAPI (vaping associated pulmonary injury) cases, our HIPPO medical editorial team review the clinical presentation and latest management recommendations for this lung disease. Mizuho Morrison and Sol Behar discuss a recent case, and review the hot-off-the-press published CDC health alert. Take a listen! Pearls: There has been a recent explosion in vape associated pulmonary injury, with serious morbidity and mortality. VAPI has been more commonly associated with THC-containing products ,although a wide variety of nicotine containing products and devices have been reported. Symptoms:  Constitutional symptoms (100%) Respiratory distress and cough (98%) GI symptoms: nausea, vomiting, diarrhea (80%) Fever (30%) Diagnosis: Vaping in past 90 days, bilateral pulmonary infiltrates on imaging, Ground-glass appearance noted on CT chest. Absence of detectable bacterial/viral infection.  Treatment:  Respiratory support Steroids may be beneficial Antibiotics alone do not appear to help as this is not an infectious process, rather an inflammatory one. However given initial mixed presentation, it is not unreasonable to initiate antibiotics until pneumonia is ruled out and diagnosis is confirmed.    References:  Layden JE1,Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Preliminary Report. N Engl J Med. 2019 Sep 6.  https://www.cdc.gov/media/releases/2019/p0906-vaping-related-illness.html https://emcrit.org/ibcc/vaping-associated-pulmonary-injury/  https://health.ny.gov/press/releases/2019/2019-09-05_vaping.htm   How would you like to listen to 6 months of full episodes for free? For the month of September, when you refer a friend to sign up for Peds RAP,  you'll get 6 free months of Peds RAP for yourself--on top of the $25 Amazon gift card you get for every friend who signs up! Start sharing below! Refer a friend

AAP Says What!?: Post-Partum Depression Screening

Play Episode Listen Later Sep 1, 2019 16:24


Michael Cosimini, MD and Liza Green Golan Mackintosh, MD get together to talk about the updated AAP clinical report for post-partum depression screening that was released January of 2019, and discuss the importance of the pediatrician screening women for this perinatal mood and anxiety disorder in their clinics. They discuss when to screen, how to screen, and what resources are available for referral, in addition to discussing the effects of maternal depression on infants. Thanks for listening to Peds RAP on iTunes. We hope you've learned some fantastic pearls so far from the free chapter segments.  How would you like to listen to 6 months of full episodes for free? For the month of September, when you refer a friend to sign up for Peds RAP,  you'll get 6 free months of Peds RAP for yourself--on top of the $25 Amazon gift card you get for every friend who signs up! Start sharing below! Refer a friend

Access, Equity, and School­-Based Health Centers

Play Episode Listen Later Aug 1, 2019 24:50


Jessica Schumer, MD and Andi Marmor, MD talk about the importance of social determinants for children’s health outcomes, particularly where the child lives as an important factor for their health. Jessica also talks us through school-based health centers as a model to address equity and the role pediatricians can play in advocating for children’s health. There is so much more to PedsRAP each month. For more incredible education and 42 hours of CME CLICK HERE!  

Outpatient Care of Premature Infants | Part 1

Play Episode Listen Later Jul 1, 2019 18:08


Christine Mirzaian, MD MPH, Solomon Behar, MD, and Liza Green Golan Mackintosh, MD discuss the special medical needs for infants born prematurely, including how to track an infant’s neurodevelopment accounting for their corrected gestational age, the risk and need for follow up for retinopathy of prematurity, which premature infants qualify for palivizumab, and how long to keep a premature infant on fortified formula. Subscribe to hear Part 2 and get 3.5 hours of CME each month CLICK HERE! 

Craniosynostosis: Part One

Play Episode Listen Later Jun 1, 2019 19:00


Yvonne Gutierrez MD and Parul Bhatia, MD discuss the physical exam findings associated with single suture craniosynostosis (SSCS), posterior positional plagiocephaly and posterior plagiocephaly secondary to lambdoid CS. They also talk about the two most commonly used surgical techniques used to correct SSCS and what is known about the neuro-developmental outcomes associated with SSCS.   There's so much more practice changing audio each month when you subscribe to the full show. Click here to sign up today!

MOCA: 9-12 month development

Play Episode Listen Later May 2, 2019 23:00


Carol Wilkinson MD, PhD and Lisa Patel, MD discuss normal milestones in this age group such as social behaviors like joint attention and early language and intentional movement for gross motor skills in addition to discussing red flags that would necessitate early referral to a specialist.   There is so much more to PedsRAP each month. For more incredible education and 42 hours of CME CLICK HERE!  

Claim Peds RAP

In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

Claim Cancel